Sign in
BVNKF Stock Price, Chart, Stats & News
Bavarian Nordic A/S
Save
Bavarian Nordic A/S (BVNKF) does not currently pay a dividend.
2.14B
Market cap
10.31x
Current P/E
4.90x
Forward P/E
BVNKF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Similar securities
Based on sector and market capitalization
Report issue